Article
Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.
Annals of Saudi medicine - 1 Jan 2000
Al Ashgar Hamad, Helmy Ahmed, Khan Mohamed Q, Al Kahtani Khalid, Al Quaiz Mohammed, Rezeig Mohammed, Kagevi Ingvar, Alshehri Abdullah, Al Kalbani Abdullah, Al Swat Khalid, Dahab Salim, Elkum Naser, Al Fadda Mohammed
Abstract excerpt
BACKGROUND AND OBJECTIVES: Knowledge of the predictors of sustained viral response (SVR) to pegylated interferon (PEG-INF) alfa-2a and ribavirin (RBV) therapy in patients with hepatitis C genotype-4 (HCV-4) is crucial for selecting patients who would benefit most from therapy. We assessed the predictors of SVR to this combination therapy in Saudi patients with chronic HCV-4 infection. PATIENTS AND METHODS: This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.